EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synergistic Targeting of Innate Receptors TLR7 and NOD2 for Therapeutic Intervention in Multiple Sclerosis

Magdalena Dubik iD, Joanna Marczynska-Grzelak, Michael Zaucha Sørensen, Ruthe Storgaard Dieu, Dominika Rusin, Eydís Sigurdardóttir Schiöth iD, Bita Ramazani, Rouhin Belal, Bhavya Ojha iD, Jonathan Krieger, Dina S Arengoth, Agnieszka Wlodarczyk iD und 2 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25137462 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Magdalena Dubik und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology Research, Institute of Molecular Medicine, University of Southern Denmark, Campusvej 55, DK-5000 Odense C, Denmark. Hauptthemen laut MEDLINE: Toll-Like Receptor 7, Nod2 Signaling Adaptor Protein, Encephalomyelitis, Autoimmune, Experimental, Multiple Sclerosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Danish Research Council, Danish Multiple Sclerosis Society, he European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Postdoctoral Research Fellowship Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regulation of neuroinflammation is critical for maintaining central nervous system (CNS) homeostasis and holds therapeutic promise in autoimmune diseases such as multiple sclerosis (MS). Previous studies have highlighted the significance of selective innate signaling in triggering anti-inflammatory mechanisms, which play a protective role in an MS-like disease, experimental autoimmune encephalomyelitis (EAE). However, the individual intra-CNS administration of specific innate receptor ligands or agonists, such as for toll-like receptor 7 (TLR7) and nucleotide-binding oligomerization-domain-containing protein 2 (NOD2), failed to elicit the desired anti-inflammatory response in EAE. In this study, we investigated the potential synergistic effect of targeting both TLR7 and NOD2 simultaneously to prevent EAE progression. Our findings demonstrate that simultaneous intrathecal administration of NOD2- and TLR7-agonists led to synergistic induction of Type I IFN (IFN I) and effectively suppressed EAE in an IFN I-dependent manner. Suppression of EAE was correlated with a significant decrease in the infiltration of monocytes, granulocytes, and natural killer cells, reduced demyelination, and downregulation of IL-1β, CCL2, and IFNγ gene expression in the spinal cord. These results underscore the therapeutic promise of concurrently targeting the TLR7 and NOD2 pathways in alleviating neuroinflammation associated with MS, paving the way for novel and more efficacious treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 7Nod2 Signaling Adaptor ProteinEncephalomyelitis, Autoimmune, ExperimentalMultiple SclerosisAnimalsMiceMice, Inbred C57BLImmunity, InnateFemaleSpinal CordMembrane GlycoproteinsInterferon Type ISignal Transduction

Stichwörter der Autor:innen

NOD2TLR7experimental autoimmune encephalomyelitissynergytype I IFN

Substanzen

Toll-Like Receptor 7Nod2 Signaling Adaptor ProteinNod2 protein, mouseTlr7 protein, mouseMembrane GlycoproteinsInterferon Type I

Autor:innen und Institutionen

  • Department of Neurobiology Research, Institute of Molecular Medicine, University of Southern Denmark, Campusvej 55, DK-5000 Odense C, Denmark.

ORCID-Profile: Magdalena Dubik, Eydís Sigurdardóttir Schiöth, Bhavya Ojha, Agnieszka Wlodarczyk, Reza Khorooshi

Förderung

  • The Danish Research Council
  • Danish Multiple Sclerosis Society
  • he European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Postdoctoral Research Fellowship Programme
  • A.P. Møller Fonden
  • Direktør Ejnar Jonasson kaldet Johnsen og hustrus mindelegat
  • EU.MSCA (Marie Sklodowska- Curie Individual Actions agreement No 813263) ITN PMSMatTrain
  • Danish Research Council
  • European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Postdoctoral Research Fellowship Programme

Zitieren

APA

Dubik, M., Marczynska-Grzelak, J., Sørensen, M. Z., Dieu, R. S., Rusin, D., Schiöth, E. S., Ramazani, B., Belal, R., Ojha, B., Krieger, J., Arengoth, D. S., Wlodarczyk, A., Owens, T., & Khorooshi, R. (2024). Synergistic Targeting of Innate Receptors TLR7 and NOD2 for Therapeutic Intervention in Multiple Sclerosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137462

Vancouver

Dubik M, Marczynska-Grzelak J, Sørensen MZ, Dieu RS, Rusin D, Schiöth ES, et al. Synergistic Targeting of Innate Receptors TLR7 and NOD2 for Therapeutic Intervention in Multiple Sclerosis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137462

BibTeX
@article{Dubik2024,
  author = {Dubik, Magdalena and Marczynska-Grzelak, Joanna and Sørensen, Michael Zaucha and Dieu, Ruthe Storgaard and Rusin, Dominika and Schiöth, Eydís Sigurdardóttir and Ramazani, Bita and Belal, Rouhin and Ojha, Bhavya and Krieger, Jonathan and Arengoth, Dina S and Wlodarczyk, Agnieszka and Owens, Trevor and Khorooshi, Reza},
  title = {Synergistic Targeting of Innate Receptors TLR7 and NOD2 for Therapeutic Intervention in Multiple Sclerosis},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25137462}
}
Kostenlos starten →